California Legislature · 2021-2022 Regular Session
Introduced
AB 264
California Competes tax credit: pharmaceutical companies
Author:
Randy Voepel
(R-AD71)
Latest action:
Introduced
(Jan 15, 2021)
Current location: CX19 · Desk
Version history
1 version — latest: Introduced (Jan 15, 2021)
- Jan 15, 2021 Introduced leginfo →
Action history
-
Jan 15, 2021 Read first time. To print. Assembly
-
Jan 16, 2021 From printer. May be heard in committee February 15. Assembly
-
Jan 28, 2021 Referred to Com. on REV. & TAX. Assembly
-
Mar 22, 2021 In committee: Hearing postponed by committee. Assembly
-
Jan 31, 2022 Died pursuant to Art. IV, Sec. 10(c) of the Constitution. Assembly
-
Feb 1, 2022 From committee: Filed with the Chief Clerk pursuant to Joint Rule 56. Assembly
Lobbying activity
FPPC lobbying disclosures whose activity descriptions mention AB 264, scoped to filings whose coverage period extends through or beyond this bill's introduction date.
Note: CalAccess lobby filings reference bills by measure number only — no session tag. When the same measure number has existed in earlier sessions (e.g. a previously chaptered bill still being lobbied on for implementation), some of those filings may appear here even though they relate to a different bill. Use the activity descriptions to disambiguate.
| Period | Form | Filer | Firm / Employer | Lobbying Activity | Filing |
|---|---|---|---|---|---|
| 01/01/2023–03/31/2023 | Employer Report | FACULTY ASSOCIATION OF CALIFORNIA COMMUNITY COLLEGES | FACULTY ASSOCIATION OF CALIFORNIA COMMUNITY COLLEGES | California State Legislature, Governor's Office, Department of Finance AB 260, 264, 395, 811, 1142, 1190 SB 444, 467 Community College Budget | #2808164 |
| 01/01/2023–03/31/2023 | Employer Report | SAN JOSE-EVERGREEN COMMUNITY COLLEGE DISTRICT | — | AB 25, 359, 680, 789, 1062, 1245, 1540, 290, 377, 569, 1575, 247, 264, 368, 557, 610, 1040, 1541, 358, 395, 689, 811, 1346, 1370, 1524; SB 307, 333, 629, 444, 791; LEGISLATURE, GOVERNOR NEWSOM RE: HIGHER EDUCATION BUDGET PROPOSAL FOR HIGHER EDUCATION, CAL GRANT REFORM, AND STUDENT HOUSING FUNDING; LEGISLATURE RE: BUDGET | #2810838 |
| 07/01/2021–09/30/2021 | Employer Report | ABBVIE | — | AB 71, AB 248, AB 249, AB 264, AB 347, AB 407, AB 458, AB 593, AB 654, AB 671, AB 789, AB 904, AB 933, AB 1050, AB 1130, AB 1178, AB 1278, AB 1400, SB 46, SB 48, SB 250, SB 252, SB 260, SB 310, SB 368, SB 521, SB 535, SB 568, SB 605, SB 852 Implementation, and Hep C Issues. | #2616383 |
| 07/01/2021–09/30/2021 | Employer Report | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | — | AB 71, 248, 249, 264, 347, 407, 458, 593, 654, 671, 789, 904, 933, 1050, 1130, 1178, 1278, 1400; SB 46, 48, 247, 250, 252, 260, 310, 368, 521, 535, 568, 605 | #2625358 |
| 04/01/2021–06/30/2021 | Employer Report | ABBVIE | — | AB 71, AB 248, AB 249, AB 264, AB 347, AB 407, AB 458, AB 593, AB 654, AB 671, AB 789, AB 904, AB 933, AB 1050, AB 1130, AB 1178, AB 1278, AB 1400, SB 46, SB 48, SB 250, SB 252, SB 260, SB 310, SB 368, SB 521, SB 535, SB 568, SB 605, SB 852 Implementation, and Hep C Issues. | #2598857 |
| 01/01/2021–03/31/2021 | Employer Report | ABBVIE | — | AB 71, AB 248, AB 249, AB 264, AB 347, AB 407, AB 458, AB 593, AB 654, AB 671, AB 789, AB 904, AB 933, AB 1050, AB 1130, AB 1178, AB 1400, SB 46, SB 48, SB 250, SB 252, SB 260, SB 310, SB 368, SB 521, SB 535, SB 568, SB 605, SB 852 Implementation, Hep C Issues | #2573212 |
| Period | Form | Employer | Firm / Filer | Fees | Reimb. | Period Total | Cumulative | Lobbying Activity | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 01/01/2023–03/31/2023 | Firm Activity (payments) | FACULTY ASSOCIATION OF CALIFORNIA COMMUNITY COLLEGES | W STRATEGIES, LLC | $15,000 | $0 | $15,000 | $15,000 | AB 260, AB 264, AB 395, AB 811, AB 1142, AB 1190; SB 444, SB 467; LEGISTLATURE, GOVERNOR'S OFFICE, CA DEPARTMENT OF FINANCE RE: COMMUNITY COLLEGE BUDGET | #2812127 |
| 07/01/2021–09/30/2021 | Firm Activity (payments) | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | FERNANDEZ CERVANTES GOVERNMENT AFFAIRS | $12,500 | $0 | $12,500 | $50,000 | LEGISLATURE RE: AB 71, 248,249, 264, 347, 407, 458, 593, 654, 671, 789, 904, 933, 1050, 1130, 1178, 1278, 1400, SB 46, 48, 250, 252, 260, 310, 368, 521, 535, 568, 605 | #2622808 |
| 04/01/2021–06/30/2021 | Firm Activity (payments) | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | FERNANDEZ CERVANTES GOVERNMENT AFFAIRS | $25,000 | $0 | $25,000 | $37,500 | AB 71, 248,249, 264, 347, 407, 458, 593, 654, 671, 789, 904, 933, 1050, 1130, 1178, 1278, 1400, SB 46, 48, 250, 252, 260, 310, 368, 521, 535, 568, 605 | #2601593 |
| 01/01/2021–03/31/2021 | Firm Activity (payments) | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | FERNANDEZ CERVANTES GOVERNMENT AFFAIRS | $12,500 | $0 | $12,500 | $12,500 | AB 71, 248,249, 264, 347, 407, 458, 593, 654, 671, 789, 904, 933, 1050, 1130, 1178, 1400, SB 46, 48, 250, 252, 260, 310, 368, 521, 535, 568, 605 | #2581200 |